Skip to content

Publications
Partner/Investor Opportunities
Contact Us

Publications
Partner/Investor Opportunities
Contact Us

About
- Leadership
- Investors
Autoimmune
Basics, MHC II
Inhibition
PV-3212 Drug
Candidate for MS
Pipeline
Other
Opportunities/
Platform
- DR15 Associated Diseases
- Other Autoimmune Disease Targets
Drug
Discovery
Services

About
- Leadership
- Investors
Autoimmune
Basics, MHC II
Inhibition
PV-3212 Drug
Candidate for MS
Pipeline
Other
Opportunities/
Platform
- DR15 Associated Diseases
- Other Autoimmune Disease Targets
Drug
Discovery
Services

About
- Leadership
- Investors
Autoimmune
Basics, MHC II
Inhibition
PV-3212 Drug
Candidate for MS
Pipeline
Other
Opportunities/
Platform
- DR15 Associated Diseases
- Other Autoimmune Disease Targets
Drug
Discovery
Services

About
- Leadership
- Investors
Autoimmune
Basics, MHC II
Inhibition
PV-3212 Drug
Candidate for MS
Pipeline
Other
Opportunities/
Platform
- DR15 Associated Diseases
- Other Autoimmune Disease Targets
Drug
Discovery
Services

Sitemap

Print Friendly, PDF & Email

Home
About
- Leadership
- Investors
Autoimmune Basics, MHC II Inhibition
PV-3212 Drug Candidate for MS
Pipeline
Other Opportunities/ Platform
- DR15 Associated Diseases
- Other Autoimmune Disease Targets
Drug Discovery Services
Publications
Partner/Investor Opportunities
Contact Us
Terms of Use
Privacy Policy
Sitemap

Home
About
- Leadership
- Investors
Autoimmune Basics, MHC II Inhibition
PV-3212 Drug Candidate for MS
Pipeline
Other Opportunities/ Platform
- DR15 Associated Diseases
- Other Autoimmune Disease Targets
Drug Discovery Services
Publications
Partner/Investor Opportunities
Contact Us
Terms of Use
Privacy Policy
Sitemap

About
Leadership
Investors

About
Leadership
Investors

Autoimmune Basics, MHC II Inhibition
Antigen Binding T Cell Activation
MHC Genetic Association
HLA-DRB1*15:01 (DR15) and Autoimmune Disease

Autoimmune Basics, MHC II Inhibition
Antigen Binding T Cell Activation
MHC Genetic Association
HLA-DRB1*15:01 (DR15) and Autoimmune Disease

PV-3212 Drug Candidate for MS
Therapeutic Strategy
Antagonist PV- 3212 Design
PV-3212 Preclinical R&D
Clinical Development

PV-3212 Drug Candidate for MS
Therapeutic Strategy
Antagonist PV- 3212 Design
PV-3212 Preclinical R&D
Clinical Development

Pipeline
DR15 Inhibitor for MS
DR15 Inhibitor for Goodpasture’s/Anti-GBM
DR15 Inhibitor for Parkinson’s

Pipeline
DR15 Inhibitor for MS
DR15 Inhibitor for Goodpasture’s/Anti-GBM
DR15 Inhibitor for Parkinson’s

Other Opportunities/ Platform
DR15 Associated Diseases
Other Autoimmune Disease Targets

Other Opportunities/ Platform
DR15 Associated Diseases
Other Autoimmune Disease Targets

Drug Discovery Services
Expert Medicinal Chemistry
Therapeutic Expertise and Target Classes
Client drug discovery projects
NIH Grant Support

Drug Discovery Services
Expert Medicinal Chemistry
Therapeutic Expertise and Target Classes
Client drug discovery projects
NIH Grant Support

Publications

Publications

Partner/Investor Opportunities
Contact Us
Sitemap

Partner/Investor Opportunities
Contact Us
Sitemap

© 2025 Provid Pharmaceuticals. All rights reserved.

Terms of Use
Privacy Policy

Terms of Use
Privacy Policy

Terms of Use
Privacy Policy

Terms of Use
Privacy Policy

Website by Axxiem

Share this page

Facebook

Twitter

LinkedIn

Email

.elementor-nav-menu--layout-vertical {display:none!important} #readMoreCobat1{display:none!important}